Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.2147/IJNRD.S135660 http://scihub22266oqcxt.onion/10.2147/IJNRD.S135660 C5473484!5473484!28652798     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Int+J+Nephrol+Renovasc+Dis 2017 ; 10 (ä): 129-34 Nephropedia Template TP {{tp|p=28652798|t=2017. Combined aquaretic and diuretic therapy in acute heart failure |pdf=|usr=}}{{28652798}} gab.com Text Combined aquaretic and diuretic therapy in acute heart failure JO: Int J Nephrol Renovasc Dis http://www.kidney.de/pget.php?&tw=1&pmid=28652798 #FOAvip Introduction: Acute heart failure (AHF) is a leading cause of hospitalization and readmission in the US. The present study evaluated maximum diuresis while minimizing electrolyte imbalances, hemodynamic instability, and kidney dysfunction, to achieve a euvolemic state safely in a shorter period of time. Methods and results: A protocol of combined therapy with furosemide, metolazone, and spironolactone, with or without tolvaptan and acetazolamide, was used in 17 hospitalized patients with AHF. The mean number of days on combination diuretic protocol was 3.8 days. The mean daily fluid balance was 3.0±2.1 L negative. The mean daily urine output (UOP) was 4.1±2.0 L (range 1.8?10.5 L). There were minimal fluctuations in serum electrolyte levels and serum creatinine over the duration of diuretic therapy. There was no statistically significant change in patients? creatinine from immediately prior to therapy to the last day of therapy, with a mean increase in creatinine of 0.14 mg/dL (95% CI ?0.03, +0.30, p=0.10). Conclusion: Our strategy of treating AHF by achieving high UOP, while maintaining stable electrolytes and creatinine in a short period to euvolemic state, is safe. Twit Text FOAVip Combined aquaretic and diuretic therapy in acute heart failure ????Int J Nephrol Renovasc Dis http://www.kidney.de/pget.php?&tw=1&pmid=28652798 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28652798 #FOAvip English Wikipedia <ref>{{Cite pmid|28652798}}</ref> Combined aquaretic and diuretic therapy in acute heart failure #MMPMID28652798 Goyfman M; Zamudio P; Jang K; Chee J; Miranda C; Butler J; Wadhwa NK Int J Nephrol Renovasc Dis 2017[]; 10 (ä): 129-34 PMID28652798show ga Introduction: Acute heart failure (AHF) is a leading cause of hospitalization and readmission in the US. The present study evaluated maximum diuresis while minimizing electrolyte imbalances, hemodynamic instability, and kidney dysfunction, to achieve a euvolemic state safely in a shorter period of time. Methods and results: A protocol of combined therapy with furosemide, metolazone, and spironolactone, with or without tolvaptan and acetazolamide, was used in 17 hospitalized patients with AHF. The mean number of days on combination diuretic protocol was 3.8 days. The mean daily fluid balance was 3.0±2.1 L negative. The mean daily urine output (UOP) was 4.1±2.0 L (range 1.8?10.5 L). There were minimal fluctuations in serum electrolyte levels and serum creatinine over the duration of diuretic therapy. There was no statistically significant change in patients? creatinine from immediately prior to therapy to the last day of therapy, with a mean increase in creatinine of 0.14 mg/dL (95% CI ?0.03, +0.30, p=0.10). Conclusion: Our strategy of treating AHF by achieving high UOP, while maintaining stable electrolytes and creatinine in a short period to euvolemic state, is safe. äCombined aquaretic and diuretic therapy in acute heart failure (epmc).pdf DeepDyve Pubget Overpricing